“…Abnormal expression levels of semaphorins and their receptors are commonly observed in cancers. For example, expression of the Plexin D1 receptor has been reported in tumor vasculature and in malignant cells in a wide range of human cancer types (Casazza et al, 2010;Roodink et al, 2005Roodink et al, , 2009Shalaby et al, 2012;Tseng et al, 2011). Expression levels of its Sema3E ligand appear to be positively correlated with increased metastatic disease in ovarian, melanoma, and colon cancers and with poor patient survival in colorectal and pancreatic cancers (Biankin et al, 2012;Casazza et al, 2010;Tseng et al, 2011).…”